pI: 7.0002 |
Length (AA): 483 |
MW (Da): 53112 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 6 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
5 | 482 | 1q2l (A) | 28 | 508 | 9.00 | 0 | 1 | 0.97 | -0.11 |
15 | 472 | 1hr6 (A) | 14 | 462 | 26.00 | 0 | 1 | 1.28 | -0.95 |
18 | 472 | 1hr6 (B) | 24 | 462 | 18.00 | 0 | 1 | 1.26 | -1.1 |
8 | 470 | 2a06 (A) | 2 | 441 | 18.00 | 0 | 1 | 1.21069 | -0.39 |
14 | 466 | 2a06 (B) | 18 | 439 | 22.00 | 0 | 1 | 1.21099 | -0.4 |
18 | 480 | 1hr6 (A) | 17 | 470 | 27.00 | 0 | 1 | 1.24729 | -0.16 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | amastigotes, metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_127941)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G51980 | putative mitochondrial-processing peptidase subunit alpha-1 |
Arabidopsis thaliana | AT3G16480 | mitochondrial processing peptidase alpha subunit |
Babesia bovis | BBOV_III003850 | mitochondrial processing peptidase alpha subunit, putative |
Brugia malayi | Bm1_13875 | Peptidase M16 inactive domain containing protein |
Candida albicans | CaO19.13674 | subunit of the mitochondrial processing protease |
Candida albicans | CaO19.6295 | subunit of the mitochondrial processing protease |
Caenorhabditis elegans | CELE_Y71G12B.24 | Protein MPPA-1 |
Cryptosporidium hominis | Chro.70239 | mitochondrial processing peptidase alpha subunit |
Cryptosporidium parvum | cgd7_2080 | mitochondrial processing peptidase, insulinase like metalloprotease |
Dictyostelium discoideum | DDB_G0274809 | mitochondrial processing peptidase alpha subunit |
Dictyostelium discoideum | DDB_G0290997 | peptidase M16 family protein |
Drosophila melanogaster | Dmel_CG8728 | CG8728 gene product from transcript CG8728-RA |
Echinococcus granulosus | EgrG_000058800 | mitochondrial processing peptidase |
Echinococcus multilocularis | EmuJ_000058800 | mitochondrial processing peptidase |
Homo sapiens | ENSG00000165688 | peptidase (mitochondrial processing) alpha |
Leishmania braziliensis | LbrM.33.2890 | mitochondrial processing peptidase alpha subunit, putative,metallo-peptidase, Clan ME, Family M16 |
Leishmania donovani | LdBPK_332750.1 | Mitochondrial-processing peptidase subunit alpha |
Leishmania infantum | LinJ.33.2750 | mitochondrial processing peptidase alpha subunit, putative,metallo-peptidase, Clan ME, Family M16 |
Leishmania major | LmjF.33.2610 | mitochondrial processing peptidase alpha subunit, putative,metallo-peptidase, Clan ME, Family M16 |
Leishmania mexicana | LmxM.32.2610 | mitochondrial processing peptidase alpha subunit, putative,metallo-peptidase, Clan ME, Family M16 |
Loa Loa (eye worm) | LOAG_01204 | peptidase M16 inactive domain-containing protein |
Mus musculus | ENSMUSG00000026926 | peptidase (mitochondrial processing) alpha |
Neospora caninum | NCLIV_022220 | hypothetical protein |
Oryza sativa | 4327198 | Os01g0739000 |
Oryza sativa | 4339368 | Os05g0524300 |
Oryza sativa | 4324473 | Os01g0966300 |
Plasmodium berghei | PBANKA_1237900 | mitochondrial-processing peptidase subunit alpha, putative |
Plasmodium falciparum | PF3D7_0523100 | mitochondrial-processing peptidase subunit alpha, putative |
Plasmodium knowlesi | PKNH_1009800 | mitochondrial-processing peptidase subunit alpha, putative |
Plasmodium vivax | PVX_080095 | mitochondrial processing peptidase alpha subunit, putative |
Plasmodium yoelii | PY00244 | mitochondrial processing peptidase alpha subunit homolog |
Saccharomyces cerevisiae | YHR024C | Mas2p |
Schistosoma japonicum | Sjp_0203980 | ko:K01412 mitochondrial processing peptidase [EC3.4.24.64], putative |
Schistosoma mansoni | Smp_094050.1 | mitochondrial processing peptidase non-peptidase alpha subunit (M16 family) |
Schistosoma mansoni | Smp_094050.2 | mitochondrial processing peptidase non-peptidase alpha subunit (M16 family) |
Schmidtea mediterranea | mk4.000787.04 | Mitochondrial-processing peptidase subunit alpha |
Trypanosoma brucei gambiense | Tbg.972.2.2270 | mitochondrial processing peptidase alpha subunit, putative,metallo-peptidase, Clan ME, Family M16, putative |
Trypanosoma brucei | Tb927.2.4110 | Mitochondrial-processing peptidase subunit alpha |
Trypanosoma congolense | TcIL3000_0_19100 | mitochondrial processing peptidase alpha subunit, putative |
Trypanosoma congolense | TcIL3000_2_630 | Mitochondrial-processing peptidase subunit alpha |
Trypanosoma cruzi | TcCLB.508441.80 | Mitochondrial-processing peptidase subunit alpha |
Trypanosoma cruzi | TcCLB.507547.30 | metallo-peptidase, Clan ME, Family M16 |
Toxoplasma gondii | TGME49_202680 | peptidase M16, alpha subunit, putative |
Theileria parva | TP02_0218 | ubiquinol-cytochrome C reductase complex core protein II, mitochondrial precursor, putative |
Trichomonas vaginalis | TVAG_119710 | Clan ME, family M16, insulinase-like metallopeptidase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.2.4110 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.2.4110 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.2.4110 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.2.4110 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
YHR024C | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_202680 | Toxoplasma gondii | Probably essential | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.